Cushing's syndrome secondary to inhaled corticosteroids mimicking HIV-associated lipodystrophy.
We report the case of an asthmatic man with HIV infection who was initially diagnosed with HIV treatment-associated lipodystrophy. Further investigations showed he had Cushing's syndrome secondary to 1600 microg of budesonide dry powder inhaler. Cushing's syndrome has not been reported previously on this normal dose of inhaled budesonide.
le Roux
C W
CW
Heart and Chest Clinic, Southend Associate University Hospital, Westcliff-on-sea, Essex, UK.
Beckles
M A
MA
Besser
G M
GM
Pinching
A J
AJ
Davison
A G
AG
D000280:Administration, Inhalation; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects*; D019819:Budesonide / Q000008:administration & dosage / Q000009:adverse effects*; D003480:Cushing Syndrome / Q000139:chemically induced* / Q000453:epidemiology; D003937:Diagnosis, Differential; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008060:Lipodystrophy / Q000175:diagnosis* / Q000209:etiology; D008297:Male; D008875:Middle Aged
D000305:Adrenal Cortex Hormones; D019819:Budesonide